A medical cannabis product called RSHO-X dramatically reduced epileptic seizures in a Mexican study of Lennox-Gastaut syndrome, a severe form of childhood epilepsy that responds poorly to treatment. The study covered 39 patients who had daily seizures despite being treated with at least three anti-epileptic drugs. Seventeen percent of the participants had no seizures for at […]
April 03, 2017 | Cannabis Derived Medicine
A study finds that people with uncontrolled epilepsy ? neurological disorder ? resort to cannabis products when antiepileptic drug side-effects are intolerable. Epilepsy is a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal electrical activity in the brain. University of Sydney researchers revealed that 14 […]
March 13, 2017 | Cannabis Derived Medicine, Epilepsy, News
Intense abnormal activity in well-known brain networks that occurs early in a seizure may be the key to impaired consciousness in children with absence epilepsy, new research suggests.
January 03, 2017 | Alzheimer's, Autism, Cannabis Derived Medicine, Childhood Epilepsy, Education, Epilepsy, Memory, Research, Seizures, Technology, Treatment
New open-label data from the expanded-access treatment program involving the cannabidiol Epidiolex (GW Pharma) show the median reduction in frequency of convulsive seizures after 3 months of treatment was 45% in all patients but higher in those with Dravet syndrome, among the most severe types of epilepsy. The data are “very positive and promising,” said […]
December 01, 2016 | Cannabis Derived Medicine, Epilepsy, Medicine, Neurology, News, Research, Treatment
Date: August 23, 2016 Source: Linköping University Summary: Researchers have developed in collaboration with French colleagues a small device that both detects the initial signal of an epileptic attack and doses a substance that effectively stops it. All this takes place where the signal arises — in an area of size 20chr(‘215’)20 μm known as a ‘neural pixel.’ […]
August 24, 2016 | Alzheimer's, Cannabis Derived Medicine, Childhood Epilepsy, Education, Epilepsy, Neurology, News, Prevention, Research, Seizures, Technology, Treatment
After 2 years of delays, appeals and uncertainty about availability, high-CBD, low-THC Medical Cannabis grown in Florida will finally be available next week to patients with prescriptions. Trulieve, located in Tallahassee, Florida, have announced that they have received the first formal authorization from the Florida DOH (Department of Health) to commence sales and dispensary of […]
July 21, 2016 | Cannabis Derived Medicine, Childhood Epilepsy, Education